LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) — Singlera Genomics, a company focused on the development and application of novel DNA methylation technologies to genetic diagnosis, today announced that it has entered into a research and distribution agreement with European Union-based international medical company Pure Medical.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
